We are live on ! Find out more
AVNS icon

Avanos Medical

317 hedge funds and large institutions have $1.98B invested in Avanos Medical in 2019 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 79 increasing their positions, 99 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,918% more call options, than puts

Call options by funds: $2.25M | Put options by funds: $56K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

3% more capital invested

Capital invested by funds: $1.93B → $1.98B (+$52.2M)

0.39% more ownership

Funds ownership: 95.08%95.47% (+0.39%)

6% less funds holding

Funds holding: 338317 (-21)

20% less repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 99

28% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 54

Holders
317
Holders Change
-21
Holders Change %
-6.21%
% of All Funds
6.89%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
39
Increased
79
Reduced
99
Closed
54
Calls
$2.25M
Puts
$56K
Net Calls
+$2.19M
Net Calls Change
-$2.35M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$238M +$984K +23,000 +0.4%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$215M -$1M -23,466 -0.5%
Vanguard Group
3
Vanguard Group
Pennsylvania
$196M -$1.61M -37,552 -0.8%
CIP
4
Champlain Investment Partners
Vermont
$107M +$2.29M +53,545 +2%
Victory Capital Management
5
Victory Capital Management
Texas
$99.9M +$4.06M +94,857 +4%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$96.6M -$7.52M -175,831 -7%
PIM
7
Paradice Investment Management
Colorado
$86.9M +$12.9M +301,082 +18%
State Street
8
State Street
Massachusetts
$84.2M +$143K +3,342 +0.2%
Invesco
9
Invesco
Georgia
$71.4M +$12.2M +284,234 +21%
Wellington Management Group
10
Wellington Management Group
Massachusetts
$71M +$1.17M +27,412 +2%
Goldman Sachs
11
Goldman Sachs
New York
$64.1M -$3.01M -70,389 -5%
Northern Trust
12
Northern Trust
Illinois
$59.8M +$3.67M +85,694 +7%
Macquarie Group
13
Macquarie Group
Australia
$53.8M +$6.09M +142,386 +13%
RC
14
RGM Capital
Florida
$32.8M +$30.3M +708,806 +1,659%
Wells Fargo
15
Wells Fargo
California
$32M -$24.1M -562,979 -43%
Norges Bank
16
Norges Bank
Norway
$28.4M -$3.88M -90,728 -12%
Lazard Asset Management
17
Lazard Asset Management
New York
$26.9M -$2.78M -65,054 -10%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$26.1M -$1.9M -44,405 -7%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$25.7M +$1.7M +39,678 +7%
Select Equity Group
20
Select Equity Group
New York
$21.5M +$21.1M +493,794 New
RHJA
21
Rice Hall James & Associates
California
$19.4M +$2.78M +64,967 +17%
SCP
22
Sandhill Capital Partners
New York
$17.3M +$993K +23,204 +6%
Charles Schwab
23
Charles Schwab
California
$16.1M -$101K -2,355 -0.6%
Loomis, Sayles & Company
24
Loomis, Sayles & Company
Massachusetts
$11M -$740K -17,301 -6%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$10.5M -$6.26M -146,265 -38%

AVNS Hedge Fund Activity: Q2 2019 in Review

317 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2019, worth a combined $1.98B — up 2.7% from $1.93B a quarter earlier.

Sellers outnumbered buyers: 54 funds closed out of AVNS and 39 opened new positions — a net loss of 15 holders — while 99 trimmed existing stakes and 79 added.

The largest buyer was RGM Capital, adding an estimated $30.3M. The largest seller was Wells Fargo, cutting an estimated $24.1M.

  • 317 institutional investors held Avanos Medical (AVNS) as of Q2 2019, down from 338 in Q1 2019.
  • Funds reported $1.98B of Avanos Medical stock for Q2 2019, up 2.7% quarter-over-quarter.
  • 39 funds opened new Avanos Medical positions in Q2 2019 and 54 closed out, a net change of -15 holders.
  • The largest Avanos Medical buyer in Q2 2019 was RGM Capital, an estimated $30.3M added.
  • The largest Avanos Medical seller in Q2 2019 was Wells Fargo, an estimated $24.1M sold.

Based on aggregated 13F filings for Q2 2019.